OrbiMed

United States
OrbiMed is a healthcare-dedicated investment firm, with approximately $5 billion in assets under management. OrbiMed's investment advisory business was founded in 1989 with a vision to invest across the spectrum of healthcare companies: from private start-ups to large multinational companies. OrbiMed manages the Caduceus Private Investmentsseries of venture capital funds and a family of public equity investment funds.
Founded:1989
Firm Location:United States • New Jersey • New York, New York • Chicago, Illinois • Philadelphia, Pennsylvania • San Francisco, California • Boston, Massachusetts • Bellevue, Washington • Boulder, Colorado • Hoboken, New Jersey • Hong Kong • London • San Francisco Bay Area • Israel
Investor Firms That Co-Invest with OrbiMed
Welsh, Carson, Anderson & StoweSR OneInterWestAbingworthBiomatics Capital PartnersAisling CapitalMeritech Capital PartnersF-Prime Capital Partners1955 CapitalCRVDFJ GrowthCincyTech USADomain AssociatesNew Leaf Venture PartnersRA Capital ManagementDeerfield ManagementDe Novo VenturesFrazier Healthcare PartnersJmi EquityThe Column GroupTencent HoldingsPitango Venture CapitalAtlas VentureThird Rock VenturesBDC Venture CapitalYsios CapitalHatteras Venture PartnersSamsara BioCapitalKhosla VenturesGeneral CatalystPear VCPfizer Venture InvestmentsLilly Asia VenturesNew Enterprise Associates (NEA)DCVC (Data Collective)Westlake Village BioPartnersMott Family CapitalAvoro VenturesVivo CapitalSequoia CapitalNextech InvestvenBioForbionOmega FundsAndera PartnersOsage University PartnersBorealis VenturesAdvent Life Sciences6 Dimensions CapitalAcorn BioventuresOxonian Ventures Advanced Technology VenturesU.S. Venture Partners (USVP)Versant VenturesMPM CapitalMenlo VenturesTiger Global ManagementCanaan Partners5am VenturesSeroba Life SciencesZetta Venture PartnersDimension CapitalGV (Google Ventures)Curie.BioOrbiMed AdvisorsMadrona Venture GroupSofinnova PartnersThe Founders FundMedical Excellence Capital, LLCSignet Healthcare PartnersLucid VenturesAmplitude VenturesLSPM12 - Microsoft's Venture FundCrowdQuestRibozyme PharmaceuticalsKamanu Ventures & Lightspeed Venture Partners ScoutRiverVest Venture PartnersSLR Capital PartnersOsage University Partners (OUP)Nan Fung Life SciencesXelas Consulting LLCObo
OrbiMed Team
Photo of David Bonita, General Partner at OrbiMed
David Bonita
OrbiMed·General Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Photo of Sven Borho, Managing Partner at OrbiMed
Sven Borho
OrbiMed·Managing Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in New York City (Other Lists), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A)
Photo of Evan Caplan, Partner at OrbiMed
Evan Caplan
OrbiMed·Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in SF Bay Area (CA)
Photo of Dina Chaya, Partner at OrbiMed
Dina Chaya
OrbiMed·Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in London
Photo of Iain Dukes, Venture Partner at OrbiMed
Iain Dukes
OrbiMed·Venture Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Photo of Michael Eggenberg, Partner at OrbiMed
Michael Eggenberg
OrbiMed·Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in United States
Photo of Robert Glassman, Venture Partner at OrbiMed
Robert Glassman
OrbiMed·Venture Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Photo of Rishi Gupta, Partner at OrbiMed
Rishi Gupta
OrbiMed·Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in San Francisco (CA)
Photo of Sevgi Gurkan, Venture Partner at OrbiMed
Sevgi Gurkan
OrbiMed·Venture Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in SF Bay Area (CA)
Photo of Geoffrey Hsu, General Partner at OrbiMed
Geoffrey Hsu
OrbiMed·General Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Photo of Alexandria Huynh, Analyst at OrbiMed
Alexandria Huynh
OrbiMed·Analyst
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in New York City (Other Lists), Investors in BioTech (Series A)
Photo of Mark Jelley, Partner at OrbiMed
Mark Jelley
OrbiMed·Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Photo of Chau Khuong, Partner at OrbiMed
Chau Khuong
OrbiMed·Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Photo of Kip Kitur, Principal at OrbiMed
Kip Kitur
OrbiMed·Principal
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Photo of Kevin Koch, Venture Partner at OrbiMed
Kevin Koch
OrbiMed·Venture Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in San Francisco (CA), Investors in New York
Investors in Medical Devices (Seed), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Medical Devices (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A), Investors in Medical Devices (Series A), Investors in Colorado / Utah (Other Lists), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A)
Photo of Dimitri Krainc, Venture Partner at OrbiMed
Dimitri Krainc
OrbiMed·Venture Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in Chicago (IL)
Photo of Jonathan Mandelbaum, Principal at OrbiMed
Jonathan Mandelbaum
OrbiMed·Principal
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in New York City (Other Lists), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A)
Photo of W. Carter Neild, Managing Partner at OrbiMed
W. Carter Neild
OrbiMed·Managing Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Photo of Anat Nursella, Venture Partner at OrbiMed
Anat Nursella
OrbiMed·Venture Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in Israel
Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Israel (Other Lists), Investors in BioTech (Seed), Investors in BioTech (Series A)
Photo of Topher Orr, Partner at OrbiMed
Topher Orr
OrbiMed·Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Photo of Trevor Polischuk, Partner at OrbiMed
Trevor Polischuk
OrbiMed·Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Photo of William Price, Managing Director at OrbiMed
William Price
OrbiMed·Managing Director
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Photo of Matthew Rizzo, Partner at OrbiMed
Matthew Rizzo
OrbiMed·Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Photo of William Sawyer, Partner at OrbiMed
William Sawyer
OrbiMed·Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Photo of Natasha Shervani, OrbiMed
Natasha Shervani
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York City
Investors in New York City (Other Lists), Investors in Therapeutics (Series A), Investors in Material Science (Seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Consumer Health (Seed), Investors in Drug Delivery (Seed), Investors in Medical Devices (Seed), Investors in Consumer Health (Series A), Investors in Medical Devices (Seed), Investors in Material Science (Series A), Investors in Health IT (Seed), Investors in BioTech (Seed), Investors in Health IT (Series A), Investors in Consumer Health (Series A), Investors in Digital Health (Seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Material Science (Seed), Investors in Health IT (Seed), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Seed), Investors in Drug Delivery (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Pharmaceuticals (Series A), Investors in Medical Devices (Series A), Investors in Material Science (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Digital Health (Series A), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Therapeutics (Seed)
Photo of Jonathan Silverstein, Partner at OrbiMed
Jonathan Silverstein
OrbiMed·Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Photo of Vivek Sivathanu, Principal at OrbiMed
Vivek Sivathanu
OrbiMed·Principal
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Photo of Stephen Squinto, Venture Partner at OrbiMed
Stephen Squinto
OrbiMed·Venture Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in New York City (Other Lists), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A)
Photo of C. Scotland Stevens, General Partner at OrbiMed
C. Scotland Stevens
OrbiMed·General Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Photo of Jim Sullivan, Venture Partner at OrbiMed
Jim Sullivan
OrbiMed·Venture Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in Chicago (IL)
Photo of Peter Thompson, General Partner at OrbiMed
Peter Thompson
OrbiMed·General Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY), Investors in San Francisco (CA)
Photo of Klaus Veitinger, Venture Partner at OrbiMed
Klaus Veitinger
OrbiMed·Venture Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Photo of Iris Wang, Partner at OrbiMed
Iris Wang
OrbiMed·Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in Hong Kong
Photo of Brendan Weber, Principal at OrbiMed
Brendan Weber
OrbiMed·Principal
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in United States, Investors in New Jersey
Photo of Diyong Xu, Partner at OrbiMed
Diyong Xu
OrbiMed·Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in FinTech (Series B), Investors in Health & Hospital Services (Series B), Investors in BioTech (Seed), Investors in FinTech (Seed), Investors in New York City (Other Lists), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in FinTech (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in FinTech (Seed), Investors in Health & Hospital Services (Seed)
Photo of Nate Yee, Vice President at OrbiMed
Nate Yee
OrbiMed·Vice President
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Photo of Jessica Zhang, Senior Associate at OrbiMed
Jessica Zhang
OrbiMed·Senior Associate
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)